Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
1
14%
Ph not_applicable
1
14%
Ph phase_1
2
29%
Ph phase_2
3
43%

Phase Distribution

2

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 23 (42.9%)
Phase 31 (14.3%)
N/A1 (14.3%)

Trials by Status

completed457%
terminated114%
withdrawn114%
unknown114%

Recent Activity

0 active trials
Showing 5 of 7
terminatednot_applicable

Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

NCT06199778
completedphase_2

Mechanisms of Refractory Hypertension (Reserpine)

NCT03223272
withdrawnphase_1

A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension

NCT02684786
completedphase_2

Reserpine for the Treatment of Cocaine Dependence - 1

NCT00033033
unknownphase_1

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

NCT00267657
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06199778Not Applicable

Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

Terminated
NCT03223272Phase 2

Mechanisms of Refractory Hypertension (Reserpine)

Completed
NCT02684786Phase 1

A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension

Withdrawn
NCT00033033Phase 2

Reserpine for the Treatment of Cocaine Dependence - 1

Completed
NCT00267657Phase 1

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

Unknown
NCT00000514Phase 3

Systolic Hypertension in the Elderly Program (SHEP)

Completed
NCT00000499Phase 2

Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7